SPG11, due to mutations in the spatacsin gene, is the most frequent form, including about 20% of all AR-HSP and up to 45% of AR-HSP with a thin corpus callosum (TCC) [11,12]. This evidence concerns the gene SPG11 and hereditary spastic paraplegia.